Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study.

Source:http://linkedlifedata.com/resource/pubmed/id/16283570

Download in:

View as

General Info

PMID
16283570